Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $98.9600 (0.06%) ($96.2800 - $100.2400) on Fri. Sep. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 12 | Latest Price | $98.9600(0.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -6.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.255% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $91.37(-7.67%) | Resistance Level | $108.41 | 5 Day Moving Average | $101.03(-2.05%) | 10 Day Moving Average | $103.07(-3.99%) | 20 Day Moving Average | $108.41(-8.72%) | To recent high | -21.9% | To recent low | 0.1% | Market Cap | $1.59b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |